Impact of the intake of cardiac drugs on adaptation to high temperatures in patients with cardiovascular diseases under the conditions of the abnormally hot summer of 2010


Cite item

Full Text

Abstract

AIM: To evaluate the impact of intake of cardiac drugs on adaptation to abnormal heat in patients with cardiovascular diseases (CVD)/MATERIAL AND METHODS: The study covered 188 patients with CVD, who had visited the Research Dispensary Department in January 2011. General clinical examination, biochemical blood analysis, and electrocardiography were made; the hospital anxiety and depression scale, the visual analog scale, and the questionnaire specially developed for this investigation were used. The authors considered acute myocardial infarction, acute stroke, hospital admission, a medical emergency team call, temporary disability (days), hypertensive crises, and unplanned visits to a doctor as estimated outcomes (endpoints) and the number of undesirable reactions a week during the abnormal heat and from September to December 2010 as a combined endpoint/RESULTS: There were a larger number of weekly adverse reactions than usual and a reduction in quality of life (QL) during the abnormal heat. Both an increase and a reduction in the dose of cardiac drugs during the abnormal heat were associated with its worse tolerability. The use of angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers (CCB) was an independent factor associated with the smaller number of complications during the abnormal heat. That of diuretics was an independent factor that was associated with a more decrease in QL in elderly patients during the heat. The intake of angiotensin receptor blockers (ARB) or nitrates was an independent factor associated with the larger number of complications during the abnormal heat/CONCLUSION: The use of ACE inhibitors and CCB is associated with fewer complications during the abnormal heat of 2010. The intake of diuretics in patients over 65 years of age and that of ARB or nitrates was associated with worse heat tolerance.

About the authors

F T Ageev

Научно-диспансерный отдел НИИ кардиологии им. А.Л. Мясникова РКНПК Минздрава РФ, Москва

Email: ageev@cardio.ru
121552 Москва, 3-я Черепковская ул., д. 15а

M D Smirnova

Научно-диспансерный отдел НИИ кардиологии им. А.Л. Мясникова РКНПК Минздрава РФ, Москва

O N Svirida

Научно-диспансерный отдел НИИ кардиологии им. А.Л. Мясникова РКНПК Минздрава РФ, Москва

A E Kuzmina

Научно-диспансерный отдел НИИ кардиологии им. А.Л. Мясникова РКНПК Минздрава РФ, Москва

L S Shatalina

Научно-диспансерный отдел НИИ кардиологии им. А.Л. Мясникова РКНПК Минздрава РФ, Москва

References

  1. Climate change and communicable diseases in the EU Member States. Handbook for national vulnerability, impact and adaptation assessments. European Centre for Diseases Prevention and Control, Stockholm, March 2010; 42.
  2. Ревич Б. Температурные кривые смертности и область температурного комфорта: Волны жары и смертность: Горячее лето 2010-го в Москве: http://www.polit.ru 13 сентября 2012 г.
  3. Kalkstein L.S., Smoyer K.E. The impact of climate change on human health: Some international implications. Experiencia 1993; 49: 469-479.
  4. Samet J.M., Zeger S.L., Dominici F. et al. The National Morbidity, Mortality, and Air Pollution Study (NMMAPS). Part 2. Morbidity and mortality from air pollution in the US. Boston; MA, Health Effects Institute 2000.
  5. WHO Air Quality Guidelines. Global Update 2006. www.who.int
  6. Природные пожары и аномальная жара в Российской Федерации. Медико-санитарные рекомендации 19 августа 2010 г. http://www.euro.who.int/PubRequest?language=Russian
  7. Koken P.J.M., Piver W.T., Ye F. et al. Temperature, air pollution, and hospitalization for cardiovascular diseases among elderly people in Denver. Environ Health Perspect 2003; 111 (10): 1312-1317.
  8. O'Riordan M., Barclay L. Traffic Exposure, Air Pollution Biggest Population-Level Triggers for MI. From Heartwire CME CME/CE Released: 03/02/2011/ http://www.theheart.org
  9. Burnett R.T., Dales R.E., Brook J.R. et al. Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology 1997; 8 (2): 162-167.
  10. Stöllberger C., Lutz W., Finsterer J. Heat-related side-effects of neurological and non-neurological medication may increase heat wave fatalities.Eur J Neurol 2009; 16 (7): 879-882.
  11. Kukkonen-Harjula K., Kauppinen K. Health effects and risks of sauna bathing. Int J Circumpolar Health 2006; 65 (3): 195-205.
  12. Vanakoski J., Seppälä T. Effects of a Finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers. Eur J Clin Pharmacol 1995; 48 (2): 133-137.
  13. Curriero F., Heiner K.S., Samet, J.M. et al. Temperature and mortality in 11 cities of the Eastern United States. Am J Epidemiol 2002; 155: 80-87.
  14. Kilbourne E.M. Heat-related illness: current status of prevention efforts. Am J Prevent Med 2002; 22: 328-329.
  15. Mirabelli M.C., Richardson D.B. Heat-related fatalities in North Carolina. Am J Public Health 2005; 95: 635-637.
  16. Naughton M.P., Henderson A., Mirabelli M.C. et al. Heat-related mortality during a 1999 heat wave in Chicago. Am J Prev Med 2002; 22: 221-227.
  17. Schuman S.H. Patterns of urban heat-wave deaths and implications for prevention: data from New York and St. Louis during July. Environmental Res 1966; 197 (5): 59-75.
  18. Stafoggia M., Forastiere F., Agostini D. et al. Vulnerability to heat-related mortality: a multicity, population-based, case-crossover analysis. Epidemiology 2006; 17: 315-323.
  19. Ledrans M. Étude des facteurs de risque de décès des personnes âgèes rèsidant â domicile durant la vague de chaleur d'août 2003 Institut de veille Sanitaire 2005; 114.
  20. Michenot F., Sommet A., Bagheri H. et al. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: a study from the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf 2006; 15: 735-740.
  21. Савенков М.П., Иванов С.Н., Сафонова Т.Е. Фармакологическая коррекция метеопатических реакций у больных с артериальной гипертонией. Трудный пациент 2007; 3: 17-20.

Copyright (c) 2013 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies